Buy weed Online Australia

Buy weed Online Sydney

If you want to learn more about us, you’re in the right place. Read to learn how we managed to grow our business so fast.

Shop Discreetly

You can now buy CBD cannabis oil from  marijuana dispensary and have it delivered to you in Australia nationwide.

Check stock here: Cannabis CBD Oil For Sale

You can now buy CBD cannabis oil from  marijuana dispensary and have it delivered to you in Australia nationwide.

Check stock here: Cannabis CBD Oil For Sale

Buy Medical Marijuana Strains Australia

Buy Medical Marijuana Strains Australia at cannabis Australia Dispensary. Your trusted Australian source for safe and legal marijuana.l Grade Cannabinoid.

CBD Oil or Cannabidiol is a substance either taken from marijuana or hemp that has excellent qualities when used as a food supplement.

CBD is a non-psychoactive oil without the negative effects of THC, the ingredient that gets people “high” when they smoke marijuana.click here to buy weed online in Australia

This oil, when taken from the marijuana plant, may have more than a trace of THC. However, when the oil is taken from the hemp plant,

it is totally safe and also legal around the world especially in Australia. Currently, CBD oil Australia is helping many residents get relief from a variety of ills.

buy cannabutter Australiabuy real hash onlineonline dispensary shipping the UKweed for sale Australia,weedmaps Australia, buy buds online, legal buds Australia, online dispensary shipping the USA, buy edibles online ship anywhere

Benefits

According to a study by the Australian Journal of Clinical Pharmacology, CBD oil is effective as an:

Anti-inflammatory

Antioxidant

Antipsychotic

You can now buy CBD cannabis oil from  marijuana dispensary and have it delivered to you in Australia nationwide.

Check stock here: Cannabis CBD Oil For Sale

Q&A: Retired NBA Star Al Harrington Takes the Court in Marijuana Industry

As kids growing up, we’d think professional athletes seem to be the closest earthly thing to superheros we would witness. With their larger-than-life stature and ability to perform seemingly impossible feats of athleticism, athletes having weaknesses is hard to imagine.

But then we grow up and learn that most of them barely hold their bodies together over the course of a long career, and the methods by which they do maintain their health have come under great scrutiny in recent years as society as a whole examines its own therapeutic tendencies.

Former NBA first round pick and 16-year veteran Al Harrington knows all about how injuries can take a toll on the body and prevent an athlete from reaching their true potential. When Marijuana.com asked the 1998 USA Today High School Player of the Year how diligent team doctors were in their education to players about the dangers of opioid painkillers, Harrington told us that wasn’t the case.

“Man, hell no!” Harrington exclaimed. “And a lot of times you don’t even get it from the doctor, you get it from the trainer. You’re just sitting there icing your knee after the game and the trainer walks over next to you, opens your hand, and tosses you a couple of pills. You just take them right there, and if you need more, you get more. I easily have over 500 pills at home right now, just from the recurring cycle of getting them.”

Across all major sports, team doctors are tasked with keeping the team’s players in tip-top shape so they may play the most games possible — sometimes to the detriment of the athlete. An athlete’s competitive nature and the threat of losing their lucrative job create heightened pressure to accept sometimes misguided “medical care” and get back to work. However, now we see that simply masking pain with opioids and other temporary treatments only helps the stakeholders: team owners, television networks, and fans oblivious to the problem.

Marijuana.com spoke with former NFL star Ricky Williams in late 2016 about the overprescribing of opioid painkillers to players recovering from injuries.

“Side effects varied from cramping to painful constipation. Secondarily, other players and I became dependent on it. If we didn’t have it daily, practice was a nightmare because we were in so much pain. The Toradol prevented us from realizing it. In my experience, marijuana doesn’t mask the pain like Toradol does. When I played, I smoked marijuana to manage the pain, which required me to be proactive about taking care of my body. Using Toradol makes it easy to depend on the pill or the shot to feel better.”

When a player’s career is over — the average NBA career lasts less than five years, according to the National Basketball Players Association (NBPA) — they no longer have access to the same training and medical staff looking after their every ache and pain, which can lead to self-medication and addiction.

As part of the NBPA 2016 collective bargaining agreement with the league, retired NBA players with at least three years of service time have their medical insurance covered, the first arrangement of its kind among North American professional sports leagues.

“The game has never before been more popular, and all the players in our league today recognize that we’re only in this position because of the hard work and dedication of the men who came before us,” said Houston Rockets point guard Chris Paul in a statement from the NBPA. “It’s important that we take care of our entire extended NBA family, and I’m proud of my fellow players for taking this unprecedented step to ensure the health and well-being of our predecessors.”

But health care for players would be far more effective if more therapeutic options were available to athletes to treat their wide range of ailments. Using opioid painkillers as a blanket solution for all of the acute and chronic pain an athlete experiences is merely a stopgap that can cause more harm than good.

When Marijuana.com asked Al Harrington, knowing what he knows now about medical marijuana, how his career may have played out differently had he employed cannabis to treat his pain rather than pharmaceuticals, he said: “If I could have managed my pain in the NBA the way I do now with cannabis without having to worry about testing dirty and being suspended, I definitely could have played a couple more years. And in a lot less pain, which is the key to it all.”

Harrington’s late-stage discovery of the power of cannabis led to him finding his true calling and a lucrative post-NBA career. Harrington runs Viola Brands, a multifaceted marijuana company that creates high-quality products for medical and recreational use. It’s named after his grandmother, who had a cannabis epiphany late in life and proved to Harrington just how powerful the plant could be.

Cannabis Concentrate

Viola Extracts Mandarin Jilly Live Resin

During a visit from Viola, Harrington noticed that his grandmother was taking a large number of pharmaceutical pills to treat the long list of conditions she suffers from, but they weren’t necessarily helping her all that much.

“My grandmother came to see me and and brought this big-ass pill box, so I asked her why she’s taking all this medication,” Harrington said. “She said, ‘Boy, I got diabetes, glaucoma, high blood pressure, this, that, and the third.’ I had just read something about using medical marijuana for glaucoma, but she was resistant to the idea at first.”

Then, Viola tried it.

“When I came back to check on her, she was leaning against the door, her head was down, and she was crying,” he said. “She looked up at me and said, ‘I’m cured.’ She was holding her bible. She said she had not been able to read the lines of her bible in three years. She was crying, I was crying. And that moment is what inspired me to start this business.”


Q. Can you tell me about your marijuana venture?

A. We started in 2011 as caregivers in Colorado. During that time, it was just us taking care of the cultivation space. We had cancer and HIV patients we were growing for. Fast forward to 2014, and they killed the caregiving model in Colorado, leaving us with a 12,000-square-foot building we can now only grow 16 plants in. We quickly had to figure out how to become fully legal. My wife is always complaining about smoke in the house, no matter what I use, so as a smoker and being in the industry, I asked myself how people can consume discreetly. We decided to dedicate the remainder of our grow to producing extracts.

Since then, Viola Extracts has become one of the top three concentrate companies in Colorado. We’ve expanded as a business as well, as we have a 40-acre farm in Oregon now, with six tax ID lots. In the first year, we did 40,000 square feet of canopy. When we max this whole thing out, it’ll be 240,000 square feet of canopy in Oregon. We also have a building in Michigan that’s 48,000 square feet. That space will be vertically integrated so we can cultivate, manufacture, and have a retail location there as well. We should have our licenses in July, so we’re super excited about that. In California, we did a joint venture with a company called Vertical Brands, almost like a licensing deal where they grow our genetics, they extract to our methods, and we just focus on creating amazing packaging and sales.

Q. What type of concentrates do you carry?

A. All of them. Live resin, shatter, butter, sauce, and we just added solventless extraction through water hash. We’re really excited about that product, it’s been flying off the shelves and we can’t make enough of it. We offer another product called Baller Buckets, where we offer 7 grams of live resin in a jar. Colorado has been our gold standard, that’s where we get all of our information, all of our knowledge. As we grow there, we’ll just be bringing those same methods to other states.

Q. What was your experience with cannabis when you were younger, in your playing days?

A. Growing up as a kid, we stayed away from all that stuff, it was a no-no in my house. As a professional, I’ve always had teammates that use. Every team always had at least one player. And a lot of times they were the better players on the team. So, I’ve always known or seen that if you do smoke, it doesn’t make you play any worse, but it still wasn’t for me at the time.

After my grandmother’s experience, I had to get a meniscus surgery and it turned into a staph infection. So I had to get like 17 surgeries over the course of two weeks. It was crazy.

I went to Vail Colorado for one of my last procedures and someone recommended I try THC and CBD for my recovery. I promise you, ever since then I have not touched pharmaceutical drugs and I’ve had three surgeries since. I still play basketball semi-professionally and I manage all my pain through cannabis. I feel like cannabis saved my life.

It’s difficult to deny the immense therapeutic power of medical marijuana when you witness success stories like the ones Al Harrington and his grandmother Viola experienced.

“I just feel like the athletes should have an option,” Harrington said. “I feel like if they get on a regimen that works for them, they can effectively manage their pain and recovery without taking all those drugs.”

“They have these commercials with people skipping in the sun and clam this drug will fix this or that, but then they list all these side effects such as sudden death, internal bleeding, eyeballs falling out. Cannabis is all natural, it comes from the ground. But yet it’s still illegal.”


LegalMarketReport_B-1-702x336

Analysts: Global Marijuana Market Generates $9.5 Billion in Spending

The cannabis industry is plowing full steam ahead despite political opposition, reaching nearly $9.5 billion in consumer spending worldwide last year, $8.5 billion of that generated in the US, according to a new report from Arcview Market Research and BDS Analytics.

And, this year for the first time, adult use is expected to outpace medical use.

The report, “The State of Legal Marijuana Markets,” released Tuesday, June 5, 2018, might be viewed as an affirmative referendum on cannabis use.

Politicians who supported adult use cannabis at one time had to worry about losing voters in doing so. No longer.

“I think the votes are in,” said Tom Adams, managing director and principal analyst of BDS Analytics. “Really, the political risk now lies with the prohibitionists’ side, which is at risk of losing votes. That’s a real turning of the tables. That’s why you are seeing this flood of people changing their views.”

Adams, one of the authors of the report, pointed as evidence for his statement to an about-face on cannabis from prominent Republicans over the past year, including former Speaker of the House John Boehner, Utah Sen. Orrin Hatch, Colorado Sen. Cory Gardner and North Carolina Sen. Thom Tillis.

The report chalks up a large share, 31 percent, of US growth to the five states that had adult-use retail stores operating by the end of 2017 —Colorado, Washington, Oregon, Alaska, and Nevada.

The report also offers a bright forward-looking assessment of the cannabis market.

Recreational sales that began in California at the start of 2018 increased the number of adults legally able to purchase adult-use cannabis products globally by nearly threefold from 17 million to 47 million in the legalized states. That headcount will jump to more than 75 million later in 2018 with the anticipated addition of Canada to the ranks of markets where cannabis can be sold to all adults, the report notes.

The report shows that Oregon leads the nation for adults reporting they consumed cannabis over the past six months (35 percent), followed by Washington (31 percent), Colorado (25 percent) and California (23 percent).

The report highlights adult-use as the key driver of consumer spending worldwide by 2022, tripling the figure to $32 billion, while US spending alone is expected to $23.4 billion.

Adult-use appears to be outpacing medical use, a milestone that wasn’t expected to occur for at least another year.

The medical portion of the market is expected to drop to 41 percent in 2018 as the Nevada, California, and Canada recreational markets explode, the report stated.

By 2022, the medical component of worldwide legal sales will shrink to just 35 percent due to continued substantial growth in those three markets, plus the launch of new adult-use markets already approved in Maine and Massachusetts, as well as those expected to launch during the forecast period.

That’s not to say medical sales are faltering, they’re just becoming a smaller percentage of the overall market, Adams said.

The threshold of adult-use surpassing medical marijuana was expected to be reached in 2019, according to the 2017 forecast.

“We’ve moved up by a year which we think adult spending surpasses medical,” he said. “We’ve now got that in the forecast model for 2018.”

The report shows continued growth in the medical cannabis market as numerous states line up to allow medical marijuana. “Overseas will be almost entirely medical for years to come,” Adams added.

Legal cannabis will likely remain predominantly medical-use worldwide until the end of the 2022 forecast period, with medical cannabis patient numbers outside of North America expected to skyrocket from 7 percent in 2017 to 44 percent by 2022.

Germany’s authorizing of medical-use sales in 2017 represents “an enormous step forward for the world­wide legal cannabis market,” the report states. “To date, only a handful of countries have authorized a few thousand patients each to be treated for very narrow lists of conditions with very limited numbers of pharmaceuticals — often synthetics.”

The report notes that, in addition to sales, cannabis investment is on its way up.

The cannabis market saw its first $5 billion company this past year when Canadian licensed producer Canopy Growth reached that capitalization at the end of 2017, in which it also generated $54 million in revenue.

In the US, public equity markets have generally been closed to plant-touching cannabis companies, but that is changing.

“There are now hundreds of private equity funds, family offices, and high-net-worth individuals replacing the friends-and-family investors of just a few years back, and they have made available several billion dollars in seed and expansion funding to both plant-touching and ancillary companies in the hopes of a big payoff when federal prohibition ends,” the report stated.

David Rheins, founder and executive director of the Marijuana Business Association, sees the report as a clear signal that legal cannabis has gone mainstream, and that the path has been cleared for “big marijuana” to take over.

“Mom-and-pop entrepreneurs, motivated by an equal mix of activism and opportunity, are quickly being displaced, or subsumed, by big corporate entities who are finally off the sidelines and making serious investments for the first time,” Rheins said. “Big Marijuana is here to stay.”

Adams said the rapid growth of the cannabis market is because it’s unlike other new product categories, such as the Internet, cable television, or organic foods — all of which had to prove to consumers why the product was useful and what it could do for them.

“Cannabis, on the other hand, has just been quietly an illicit product for 50 years, getting the consumer educated and making the appeal clear,” he said.

Gallup reported last year that a record 64 percent of Americans believe cannabis should be legalized, and for the first time in Gallup’s nearly 50 years of polling, a majority of Republicans agreed.

Such polling, the change in direction from Republicans such as Boehner, Hatch, Gardner, and Tillis, a marketplace that continues to exceed expectations, all points to one inevitability, Adams believes.

The time will soon come for cannabis to taken off the list of Schedule I drugs in the Controlled Substances Act.

“The legalization is coming. That’s the bottom line,” Adams said. “It’s pretty clear that this is the last gasps of the prohibitionists.”

Gallup Poll: Majority of Americans Are High on Marijuana … Being Legal

Americans’ support for marijuana legalization is at a record high.

With cannabis already legal in several US states, a recent Gallup poll found that 64 percent of Americans are saying its use should be made legal. The poll also found, that for the first time, a majority of Republicans also support marijuana legalization – by 51 percent.

Fred Smoller, a political science professor at Chapman University in Orange, California, attributes the numbers to the generation polled.

“Woodstock,” he said. “That generation [baby boomers]… it’s a cohort, they’ve always viewed marijuana differently than the people before them. … They grew up laughing at ‘Reefer Madness.’”

He said while some attitudes might have changed regarding marijuana, the difference lies in the demographic.

According to a Gallup news article, Gallup first asked adults nationally about their views on marijuana in 1969, when only 12 percent were in support of legalization.

In the recent study, results are based on phone interviews conducted Oct. 5, 2017, to Oct. 11, 2017, of a random sample of 1,028 adults 18 and older from all 50 US states and Washington, DC.

Whether this increase in marijuana legalization support will soon lead to federal legalization remains to be seen. Smoller doesn’t think so.

“No,” he said. “The laws will remain on the books but won’t be enforced. This allows electeds to appeal to different groups. It’s kinda like [former President Bill]Clinton saying he smoked pot but didn’t inhale.”

On the political level, there is a steady stream of activity in regard to the topic of marijuana.

Senate Minority Leader Chuck Schumer announced on April 20, 2018, his support for decriminalizing marijuana federally and his plans to introduce new legislation in the Senate, according to a press release on his website.

“The time has come to decriminalize marijuana,” Schumer said in the statement. “My thinking – as well as the general population’s views – on the issue has evolved, and so I believe there’s no better time than the present to get this done. It’s simply the right thing to do. This legislation would let the states be the laboratories that they should be, ensure that woman and minority owned business have a fair shot in the marijuana industry, invests in critical research on THC, and ensures that advertisers can’t target children – it’s a balanced approach.”

In an April 16, 2018, press release on his website, California Republican Rep. Dana Rohrabacher was said to be preparing stand-alone legislation called the Cannabis States’ Rights Act, which would permanently restrain federal enforcement of marijuana laws in states that have legalized it.

“This is a fundamental issue of federalism and freedom, as state after state moves to take marijuana out of the hands of the cartels and place it in a competitive market where consumers can be assured of product safety,” Rohrabacher said in the statement. “It also encourages more exploration of medical uses for cannabis, which has shown unquestionable promise in the treatment of multiple ailments and disorders.”

But the support in the direction of marijuana legalization clearly isn’t unanimous.

The Department of Justice on Jan. 4 issued a memo on federal marijuana enforcement policy, returning to the rule of law that deems it a controlled substance and enforces it as such, according to a press release on the Justice Department website.

“It is the mission of the Department of Justice to enforce the laws of the United States, and the previous issuance of guidance undermines the rule of law and the ability of our local, state, tribal, and federal law enforcement partners to carry out this mission,” US Attorney General Jeff Sessions said in the statement. “Therefore, today’s memo on federal marijuana enforcement simply directs all U.S. Attorneys to use previously established prosecutor principles that provide them all the necessary tools to disrupt criminal organizations, tackle the growing drug crisis, and thwart violent crime across our country.”

FILE - In this Jan. 27, 2015 file photo, a man stands in a poppy flower field in the Sierra Madre del Sur mountains of Guerrero state, Mexico. Opium poppy growers in southern Mexico say prices for their product have been driven so low that they are turning in desperation back to another crop they know well: marijuana. (AP Photo/Dario Lopez-Mills, File)

Mexico Opium Poppy Growers See Price Drop, Turn to Marijuana

TENANTLA, Mexico (AP) — Opium poppy growers in southern Mexico who helped fuel the U.S. heroin epidemic say prices for their product have been driven so low — apparently by the use of synthetic opioids like fentanyl — that they are turning in desperation back to another crop they know well: marijuana.

Beset by poverty and joblessness, farmers in the hills around the Guerrero state hamlets of Tenantla and Amatitlan say that prices for opium paste — which oozes from the bulbs of poppies after they’re cut — have fallen so low they don’t even pay for the cost of planting, fertilizing, irrigating, weeding and harvesting the raw material for heroin.

This June 19, 2018 photo shows a view of Tenantla surrounded by mountains in Guerrero State, Mexico. Beset by poverty and joblessness, farmers in the hills around the Guerrero state hamlets of Tenantla and Amatitlan say that prices for opium paste have fallen so low they don’t even pay for the cost of planting, fertilizing, irrigating, weeding and harvesting the raw material for heroin. (AP Photo/Mark Stevenson)

One local farmer points to a former opium poppy field tucked into the fold of steep hillside. The dried stalks of the poppy plants from last year’s harvest can be seen sticking out among the 2- and 3-foot-tall stands of marijuana planted this year.

“We’ll probably keep planting both,” said the stocky farmer who asked not to be named for fear of arrest.

But a rail-thin grower with narco-style chain necklaces in the nearby hamlet of Amatitlan said he won’t plant poppies again.

“If I’m working three months to make just 5,000 pesos ($250), I might as well do something else,” he said. “It’s easier to plant marijuana. It isn’t so prone to pests.”

What has him and other farmers in the region desperate is a huge drop in the prices that local drug gangs pay for a kilogram of opium paste. At its height a few years ago, the farmers say they could get 20,000 or 25,000 pesos ($1,000 to $1,250) per kilogram. This year, prices have dropped to 5,000 ($250) per kilo.

The farmer in Amatitlan blames the price drop on the “sinteticos” — synthetic opioids like fentanyl. Drug cartels are increasingly either selling fentanyl in pill form or cutting heroin with fentanyl to boost its potency, thus lessening their need for naturally grown opioids.

That’s already having an effect on America’s opioid problem as well, according to U.S. law enforcement.

“Some heroin indicators suggest fentanyl is significantly impacting market share and, in a few markets, even supplanting the heroin market,” the Drug Enforcement Administration said in its 2017 National Drug Assessment report.

A U.S. official, who was not authorized to be quoted by name or agency, noted that for traffickers, there are advantages to synthetics. They are not affected by rainfall, raids or rival gangs and can be ordered by mail from Chinese labs, avoiding much of the labor and conflict involved in buying small amounts of opium paste from farmers and processing them into heroin and then smuggling it to the U.S. market.

Still, DEA figures indicate the flow of organic heroin has been high and rising in recent years, and the official estimated it could take five to 10 years for growth of fentanyl to put a significant dent in that.

In this June 19, 2018 photo, armed vigilantes patrol Tenantla, in Guerrero state, Mexico. The vigilantes say they are defending the village against gangs that roam the area, where marijuana and opium poppy production is common. (AP Photo/Mark Stevenson)

There’s still “plenty of heroin flowing north,” the official said.

However, officials in Guerrero state — one of Mexico’s largest growing areas, together with northern states like Durango, Chihuahua and Sinaloa — say that on the ground, they’re already seeing the effects of the drop in opium prices.

“The increase in synthetic drugs is causing the price of naturally grown drugs like opium to fall, and that is hitting the income of the criminal groups,” said Guerrero state security spokesman Roberto Alvarez.

“The gangs are experiencing an economic crisis, which is causing criminals to diversify their activities,” said  Alvarez, noting that some gangs have taken to carjacking vehicles on the heavily travelled toll highway that runs from Mexico City to Acapulco, something that didn’t use to happen.

“They are turning to extortion or kidnapping, as well,” Alvarez notes. “All of a sudden they see their income drop and so they seek out other revenues, like kidnapping, extortion.”

This month, for example, a city on the other side of the mountains in Guerrero saw its local PepsiCo distribution plant close because of gang extortion demands — just months after the Coca Cola plant there closed for the same reason. Such large companies had previously gone largely untouched by gang violence.

Government figures suggested opium eradication nationwide remains strong and may even be rising: In the first four months of 2018, soldiers destroyed 12,834 hectares (31,713 acres) of opium poppies, and only 720 hectares of marijuana.

But that also suggests that the Mexican army is placing a higher focus on eradicating poppies than on marijuana; after all, the army has seized an average of 850 tons harvested and dried marijuana annually in recent years, suggesting there are hundreds of thousands of acres under cultivation.

Anecdotally, farmers in Guerrero say authorities do focus more on eradicating opium. They point to at least one field in a narrow valley that was sprayed with an herbicide by a government plane about three months ago; no marijuana plots have been raided in the same valley.

Locals say farmers have been planting both crops here since at least the 1970s, and prices for both have fallen steadily. Bulk marijuana that once sold for as much as $40 per kilo now sells for $10. Farmers don’t make much money on either crop.

The deciding factor for many farmers is the cost and effort involved. Opium poppies must be irrigated, well-fertilized, must get regular applications of pesticides. Harvesting opium is a delicate, time-consuming task: the poppy bulb is cut and carefully scraped, often by farmhands who can collect only a small amount each day.

While some farmhands charge as little as $7 per day, poppy workers charge double that, eating up any potential profit. Marijuana isn’t as prone to plant pests, and harvesting is simpler.

And there is also the possibility that marijuana growing might be legalized. Mexico has already approved some personal-use growing, though it hasn’t legalized commercial crops.

Some think legalized, commercial marijuana growing might help these mountain villages, which have been plagued by violence since opium surged in price and warring gangs fought for control of the area. Heavily armed vigilantes with assault rifles now patrol hamlets like Tenantla 24 hours per day.

Humberto Nava Reyna, the head of the Supreme Council of the Towns of the Filo Mayor, a group that promotes development projects in the mountains, said, “We all know the economy of this region, the high mountains of Guerrero, has been based on growing marijuana and opium poppies. … What we are asking is that be regulated and regularized.”

In larger terms, it is all just another chapter in the desperation-driven, cyclical farming history of the tropics, with farmers living through booms in crops like coffee, only to see them bust because of plant diseases or price drops.

“Back in the 1970s, farmers planted more marijuana, and when the marijuana went down, opium poppies went up, and now they’re looking to turn to regulated marijuana growing,” said Nava Reyna.